| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 119,433 | 117,047 | 120,860 | 139,431 | | Cost of Revenue | 22,527 | 22,593 | 24,378 | 23,848 | | | Gross Profit | 96,906 | 94,454 | 96,482 | 115,583 | | | Operating Expenses | | Research Development | 22,378 | 23,023 | 24,919 | 25,489 | | Selling General and Administrative | 63,228 | 57,336 | 58,890 | 72,321 | | Non Recurring | (101) | 80 | 5,588 | 6,915 | | Others | 2,309 | 2,474 | 2,366 | 2,334 | | | | Total Operating Expenses | 87,814 | 82,913 | 91,763 | 107,059 | | | | Operating Income or Loss | 9,092 | 11,541 | 4,719 | 8,524 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (187) | (460) | 1,229 | 1,735 | | Earnings Before Interest And Taxes | 8,905 | 11,081 | 5,948 | 10,259 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 8,905 | 11,081 | 5,948 | 10,259 | | Income Tax Expense | 3,384 | 4,175 | 2,296 | 3,807 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,521 | 6,906 | 3,652 | 6,452 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,521 | 6,906 | 3,652 | 6,452 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,521 | $6,906 | $3,652 | $6,452 |
|
0.51% Nasdaq 
Income Statement
